Long-Term Serological Response to 13-Valent Pneumococcal Conjugate Vaccine Versus 23-Valent Polysaccharide Vaccine in HIV-Infected Adults

Long-Term Serological Response to 13-Valent Pneumococcal Conjugate Vaccine Versus 23-Valent Polysaccharide Vaccine in HIV-Infected Adults

Abstract Introduction Long-term comparative immunologic response to 13-valent pneumococcal conjugate vaccine (PCV13) versus 23-valent polysaccharide vaccine (PPV23) among HIV-infected adults has not yet been investigated. Methods In this prospective pilot study, we quantified in HIV-positive adults...

Full description

Bibliographic Details
Main Authors: Simone Belmonti, Barbara Rossetti, Sara Modica, Lorenzo Paglicci, Alberto Borghetti, Arturo Ciccullo, Chiara Picarelli, Roberto Cauda, Andrea De Luca, Francesca Montagnani, Francesca Lombardi
Format: Article
Language:English
Published: Adis, Springer Healthcare 2019-07-01
Series:Infectious Diseases and Therapy
Subjects:
HIV
PCV13
Pneumococcal vaccination
PPV23
Serologic response
Streptococcus pneumoniae
Online Access:http://link.springer.com/article/10.1007/s40121-019-0256-z

Internet

http://link.springer.com/article/10.1007/s40121-019-0256-z

Similar Items